68-year-old man with vision loss in the right eye on awakeni | Figure 1

68-year-old man with vision loss in the right eye on awakening

What is the role of the primary care or emergency medicine physician?

What is the role of the ophthalmologist?

What is the treatment?

Patients with nonarteritic AION should be treated for underlying cardiovascular disease and/or aggravating risk factors. In select cases, corticosteroid therapy may also be considered in the acute setting.

Arteritic AION is managed with systemic corticosteroid therapy, starting with emergency high-dose intravenous steroids for 2-3 weeks, followed by a taper and lifelong low-dose regimen. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) should be monitored to guide steroid taper. Follow-up with a rheumatologist is recommended to consider a steroid-sparing agent.

Review the full case on the Academy website for more details, including links to educational resources on key topics related to the case.

Diagnosis added by author

The image is consistent with a diagnosis of nonarteritic anterior ischemic optic neuropathy (AION). AION is a loss of vision due to interrupted blood flow to the optic nerve head. A common cause of permanent vision loss in patients older than 50, it is characterized by a sudden, painless decline of vision—either unilateral or bilateral—typically noticed upon waking. AION is characterized as arteritic or nonarteritic.